CIK 0001054102 · Non-accelerated filer<br>Smaller reporting company
INTERPACE BIOSCIENCES, INC.
Sign in to watch- Ticker
- IDXG
- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 222919486
- Phone
- 412-224-6100
- Business address
- WATERVIEW PLAZA, SUITE 310, 2001 ROUTE 46, PARSIPPANY, NJ, 07054
- Former names
- Interpace Diagnostics Group, Inc., PDI INC, PROFESSIONAL DETAILING INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-03-07 | Richard Gregory Chief Commerical Officer | Grant or award · Stock Option (right to buy) | +112,000 | 112,000 | ||
| 2018-03-07 | Early James Chief Financial Officer | Grant or award | +14,000 | 14,000 | ||
| 2018-03-07 | Early James Chief Financial Officer | Grant or award · Stock Option(right to buy) | +56,000 | 56,000 | ||
| 2018-02-26 | Richard Gregory Chief Commerical Officer | Option exercise | +2,000 | 3,241 | ||
| 2018-02-26 | Richard Gregory Chief Commerical Officer | Option exercise · Restricted Stock Units | −2,000 | 2,000 | ||
| 2017-09-26 | STOVER JACK E President and CEO | Grant or award · Stock Option (right to buy) | +345,000 | 345,000 | ||
| 2017-09-26 | Richard Gregory Chief Commerical Officer | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2017-09-26 | Early James Chief Financial Officer | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2017-09-25 | SULLIVAN STEPHEN J Director | Grant or award · Stock Option (right to buy) | +13,000 | 13,000 | ||
| 2017-09-25 | KEEGAN JOSEPH D Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2017-09-25 | Schnoll-Sussman Felice Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2017-03-16 | STOVER JACK E President and CEO | Grant or award · Stock Option (right to buy) | +134,602 | 134,602 | ||
| 2017-03-16 | Early James Chief Financial Officer | Grant or award · Stock Option (right to buy) | +14,475 | 14,475 | ||
| 2017-03-15 | KEEGAN JOSEPH D Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2017-03-15 | SULLIVAN STEPHEN J Director | Grant or award · Stock Option (right to buy) | +13,000 | 13,000 | ||
| 2016-10-14 | Early James Chief Financial Officer | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2016-10-14 | STOVER JACK E President and CEO | Grant or award · Stock Option (right to buy) | +326,368 | 326,368 | ||
| 2016-03-01 | Krishnamurti Nat Interim CFO | Grant or award · Restricted stock units | +60,000 | 60,000 | ||
| 2016-02-03 | SULLIVAN STEPHEN J Director | Grant or award | +100,000 | $0.47 | $47K | 197,828 |
| 2016-02-03 | STOVER JACK E Interim President and CEO | Grant or award | +100,000 | $0.53 | $53K | 197,378 |
Page 6 of 8 · 158 trades